Acromegaly Injectable Rejected; Nobel Prize Winner Dies; Obesity Doubles in Kids

— News and commentary from the endocrinology world

MedicalToday
Endo Break over a computer rendering of a man with illustrated body organs.

The investigational octreotide (CAM2029) extended-release injection for acromegaly, said developer Camurus, citing facility-related deficiencies identified during an inspection of a third-party manufacturer.

Paternal use of metformin for type 2 diabetes during sperm development wasn't tied with , a study of over 3 million pregnancies found. (The BMJ)

In a phase III trial of adults with type 2 diabetes with heart disease and/or chronic kidney disease, oral semaglutide (Rybelsus) adjunctive to standard of care reduced the risk of by 14% versus placebo, Novo Nordisk said.

Endocrinologist -- who won a Nobel Prize for discovering the hormones used by the brain to control growth, reproduction, and other bodily functions -- passed away at age 97. (New York Times)

for 12 weeks had beneficial effects on β-cell function in adults with mild type 2 diabetes. (Journal of Clinical Endocrinology & Metabolism)

Prevalence of obesity and severe obesity in the U.S. over the past two decades among people ages 2-19 years, with current rates reaching 21% and 7%, respectively. (Morbidity and Mortality Weekly Report)

Eli Lilly filed suit against for selling products claiming to contain tirzepatide (Zepbound). (Reuters)

The announced they will jointly host a series of three conferences -- slated to launch in late 2026 or early 2027 and set to run for at least 3 years -- to advance endocrine research.

Adults with on a GIP and/or GLP-1 receptor agonist for type 2 diabetes and obesity had significantly lower rates of opioid overdose and alcohol intoxication. (Addiction)

Texas is suing a doctor for on gender-affirming care for minors. (NBC News)

People with type 1 diabetes who ate spent more time in target glucose range, a study in Journal of Clinical Endocrinology & Metabolism found.

  • author['full_name']

    Kristen Monaco is a senior staff writer, focusing on endocrinology, psychiatry, and nephrology news. Based out of the New York City office, she’s worked at the company since 2015.